Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDrreddyslaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy HDFC Bank, Natco Pharma, Hindalco Industries, Axis Bank; sell TCS: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy HDFC Bank, Natco Pharma, Hindalco Industries and Axis Bank and can sell TCS.

    • Buy HPCL, Sun TV Network, Tata Consultancy Services, Bata India; sell Canara Bank: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy HPCL, Sun TV Network, Tata Consultancy Services and Bata India and can sell Canara Bank.

    • Exit Granules India on rallies: Shahina Mukadam

      Shahina Mukadam, Independent Market Expert is of the view that one may exit Granules India on rallies.

    • UBS underweight on small & midcaps but prefers bottom-up ideas; Here are its top 12 bets

      The global investment bank remains Overweight (OW) on auto parts and two-wheelers (2Ws) such as Eicher Motors.

    • Most Indian pharma players will get impacted with pricing pressure: Edelweiss Securities

      Pharma stocks have been buzzing in trade, is there more legs to this rally? In an interview with CNBC-TV18, Deepak Malik, Pharma Analyst at Edelweiss Securities shared his views and readings on the same.

    • Buy, Sell, Hold: Here are 4 stocks and 4 sectors in focus today

      Tata Motors, CESC, IT and Autos, among others, being tracked by investors on Wednesday.

    • Top buy & sell ideas by Ashwani Gujral,Mitessh Thakkar & Prakash Gaba for November 21

      Mitessh Thakkar of miteshthacker.com suggests selling ACC with a stop loss of Rs 1734 for target of Rs 1650 and advises buying Biocon with a stop loss of Rs 412 for target of Rs 445.

    • Sell Repco Home, buy Gujarat State Fertilizers, Dr Reddy’s Labs, Sun TV: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell Repco Home Finance and buy Gujarat State Fertilizers & Chemicals, Dr Reddy’s Laboratories and Sun TV Network.

    • Buy Edelweiss Financial Services, State Bank of India, Dr Reddy's Laboratories: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Edelweiss Financial Services, State Bank of India and Dr Reddy's Laboratories.

    • Sell Capital First, LIC Housing; buy Balkrishna Industries, Hindalco, UltraTech: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell Capital First and LIC Housing Finance and can buy Balkrishna Industries, Hindalco Industries and UltraTech Cement.

    • Dr Reddy's falls 3% post Q2 results; brokerages remain mixed

      Brokerage were mixed on the results, with some of them pinning hopes on approvals. A few also pointed out US business prospects for the firm.

    • Buy, Sell, Hold: 10 stocks are being tracked by analysts today

      IndiGo, JSW Steel, Dr Reddy’ and Info Edge, among others are on the radar of investors on Wednesday.

    • Buy Colgate, Dr Reddy’s Labs, Glenmark, Grasim Industries; sell Pidilite: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Colgate Palmolive, Dr Reddy’s Laboratories, Glenmark Pharma and Grasim Industries and can sell Pidilite Industries.

    • Buy Tata Global, Hero Moto, Adani Ports, Dr Reddy's Labs, Jain Irrigation: VK Sharma

      VK Sharma, Head - PCG and Capital Market Strategy at HDFC Securities suggests buying Tata Global Beverage, Hero MotoCorp, Adani Ports, Dr Reddy's Laboratories and Jain Irrigation Systems.

    • Buy RIL BPCL, Adani Enterprises, Auro Pharma, Jubilant Food; short NMDC, DCB Bank: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Adani Enterprises, Aurobindo Pharma and Jubilant Foodworks and can short NMDC and DCB Bank.

    • Market Update: Midcaps crack; SBI falls over 2%, RComm hits 1-yr low, Indiabulls Housing top loser

      The top loser in Nifty50 Index were Indiabulls Housing Finance followed by Bajaj Finance and State Bank of India while the stocks that hit new 52-week low on the Nifty were Amara Raja Batteries, Wockhardt and Reliance Communications.

    • DRL launches Renvela generic in US, price target at Rs 2200: HDFC Securities

      The pharma major Dr Reddys Laboratories (DRL) has launched kidney disease drug Renvela generic in the US market. How big an opportunity can this be for DRL and what does it do to Aurobindo Pharma. In an interview to CNBC-TV18, Amey Chalke of HDFC Securities shared his views and readings on the same.

    • Buy, Sell, Hold: Here are 7 stocks and 2 sectors being tracked by analysts today

      Coal India, Titan and GAIL, among others, are on the radar of investors on Tuesday.

    • Buy IGL, Manpasand Beverages, Dr Reddy's Lab; sell Bharti Airtel: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com advises buying IGL, Manpasand Beverages and Dr Reddy's Laboratories.

    • Dr Reddy's Laboratories may move to Rs 2600-2650: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com feels that Dr Reddy's Laboratories maybe you can get still Rs 2,600-2,650.

    • Buy Divis Laboratories, Bharat Electronics; sell Oil India: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may buy Divis Laboratories and Bharat Electronics.

    • Sell UltraTech Cement, Pidilite Industries: Mitessh Thakkar

      Mitessh Thakkar of mitesshthakkar.com is of the view that one may sell UltraTech Cement and Pidilite Industries.

    • Regulatory issues should reduce going ahead for DRL: Edelweiss Sec

      Pharma stocks have been on an upward trend. In an interview to CNBC-TV18, Deepak Malik, Pharma Analyst of Edelweiss Securities discussed what is happening in the sector.

    • Buy Torrent Pharma, Tata Consultancy Services; sell Zee Entertainment: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Torrent Pharma and Tata Consultancy Services and can sell Zee Entertainment Enterprises.

    • Buy Adani Ports, NALCO, Dr Reddy's, GSPL; sell Jet Airways, M&M: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Adani Ports and Special Economic Zone, National Aluminium Company, Dr Reddy's Laboratories and Gujarat State Petronet Limited and can sell Jet Airways and Mahindra & Mahindra.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347